European Urology Focus

Published by: Elsevier B.V.  

People

  1. Coleman
    Coleman
  2. Benfante
    Benfante
  3. Hakimi
    Hakimi
  4. Russo
    Russo
  5. Vickers
    Vickers
  6. Arcila
    Arcila
  7. Bochner
    Bochner
  8. Motzer
    Motzer
  9. Reuter
    Reuter
  10. Reznik
    Reznik

Groups

  1. Surgery (35)
  2. Urology (33)
  3. Epidemiology and Biostatistics (18)
  4. Department of Medicine (15)
  5. Genitourinary Oncology Service (14)
  6. Population Sciences Research Program (14)
  7. Solid Tumor Oncology Division (14)
  8. Survivorship Research (13)
  9. Sloan Kettering Institute Postdocs (12)
  10. Health Outcomes Research Group (11)
Search Within
Formats
  1. Journal Article (39)
  2. Review (7)
  3. Editorial (2)
  4. Miscellaneous (1)
Groups
  1. Surgery (35)
  2. Urology (33)
  3. Epidemiology and Biostatistics (18)
  4. Department of Medicine (15)
  5. Genitourinary Oncology Service (14)
  6. Population Sciences Research Program (14)

More Groups

People
  1. Jonathan Coleman (11)
  2. Abraham Hakimi (9)
  3. Nicole Benfante (9)
  4. Paul Russo (9)
  5. Andrew Vickers (8)
  6. Bernard Bochner (6)

More People

Years
  1. 2024 (3)
  2. 2023 (10)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (11)

More Years

Publishers
  1. Elsevier B.V. (49)

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrent Gleason score 6 prostate cancer after radiotherapy or ablation: Should we observe them all? Results from a large multicenter salvage radical prostatectomy consortium
    Journal Article

    Marra, G.; Calleris, G.; Conte, F.; Benfant, N.; Rajwa, P.; Ahmed, M.; Abreu, A.; Cacciamani, G.; Smith, J. A.; Joniau, S.; more...
    European Urology Focus (2024)

    Fulltext@MSK | Save
  • The highest grade group does not drive the risk of recurrence when systematic and multiparametric magnetic resonance imaging (MRI)-targeted biopsies are discordant: Preliminary findings using radical prostatectomy pathology as a surrogate for MRI-targeted biopsy grade
    Journal Article

    Scuderi, S.; Pellegrino, F.; Tin, A.; Beech, B. B.; Gandaglia, G.; Stabile, A.; Eastham, J. A.; Montorsi, F.; Briganti, A.; Vickers, A. J.
    European Urology Focus (2024)

    Fulltext@MSK | Save
  • Retroperitoneal lymph node dissection in patients with stage II seminomatous germ cell tumour
    Journal Article

    Oing, C.; Rescigno, P.; Paffenholz, P.; Heinzelbecker, J.; Patrikidou, A.; Matulewicz, R. S.; Huddart, R.
    European Urology Focus (2024)

    Fulltext@MSK | Save
  • Biparametric versus multiparametric magnetic resonance imaging for assessing muscle invasion in bladder urothelial carcinoma with variant histology using the Vesical Imaging Reporting and Data System
    Journal Article

    Arita, Y.; Kwee, T. C.; Woo, S.; Shigeta, K.; Ishii, R.; Okawara, N.; Edo, H.; Waseda, Y.; Vargas, H. A.
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
    Journal Article

    Hahn, A. W.; Kotecha, R. R.; Viscuse, P. V.; Pieretti, A. C.; Wiele, A. J.; Jonasch, E.; Lee, C. H.; Gao, J.; Zurita, A. J.; Shah, A. Y.; more...
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Outcomes of grade group 2 and 3 prostate cancer on initial versus confirmatory biopsy: Implications for active surveillance
    Journal Article

    Perera, M.; Jibara, G.; Tin, A. L.; Haywood, S.; Sjoberg, D. D.; Benfante, N. E.; Carlsson, S. V.; Eastham, J. A.; Laudone, V.; Touijer, K. A.; more...
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Bladder cancer carcinogens: Opportunities for risk reduction
    Review

    Gaffney, C. D.; Katims, A.; D'Souza, N.; Bjurlin, M. A.; Matulewicz, R. S.
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Salvage radical prostatectomy for recurrent prostate cancer following first-line nonsurgical treatment: Validation of the European Association of Urology criteria in a large, multicenter, contemporary cohort
    Journal Article

    Calleris, G.; Marra, G.; Benfant, N.; Rajwa, P.; Ahmed, M.; Abreu, A.; Cacciamani, G.; Ghoreifi, A.; Ribeiro, L.; Westhofen, T.; more...
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Thermal partial prostate ablation for intermediate- and high-risk prostate cancer: Con
    Editorial

    Gaffney, C. D.; Ehdaie, B.
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Background and update for ECOG-ACRIN EA8212: A randomized phase 3 trial of intravesical bacillus Calmette-Guérin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naïve high-grade non–muscle-invasive bladder cancer (BRIDGE)
    Review

    Kates, M.; Chu, X.; Hahn, N.; Pietzak, E.; Smith, A.; Shevrin, D. H.; Crispen, P.; Williams, S. B.; Daneshmand, S.; Packiam, V. T.; more...
    European Urology Focus (2023)

    Fulltext@MSK | Save

    • European Urology Focus – authorized name for:

    Name ISSN / ISBN Publisher
    European Urology Focus 2405-4569 European Association of Urology
    European Urology Focus 24054569 European Association of Urology
    European Urology Focus 2405-4569 European Association of Urology
    European Urology Focus 2405-4569 Unknown
    European Urology Focus 24054569 The Authors
    European Urology Focus 24054569 The Author(s)
    European Urology Focus 2405-4569 European Association of Urology
    European Urology Focus 24054569 Unknown
    European Urology Focus 2405-4569 European Association of Urology
    European Urology Focus 2405-4569 Elsevier B.V.
    European Urology Focus 2405-4569 European Association of Urology
    European Urology Focus 2405-4569 Elsevier BV
    European Urology Focus 24054569 2022
    European urology focus 24054569 Elsevier B.V.
    European Urology Focus 2405-4569 Elsevier B.V.